» Articles » PMID: 36422993

Pathophysiology and Pathogenic Mechanisms of Pulmonary Hypertension: Role of Membrane Receptors, Ion Channels, and Ca Signaling

Overview
Journal Physiol Rev
Specialty Physiology
Date 2022 Nov 24
PMID 36422993
Authors
Affiliations
Soon will be listed here.
Abstract

The pulmonary circulation is a low-resistance, low-pressure, and high-compliance system that allows the lungs to receive the entire cardiac output. Pulmonary arterial pressure is a function of cardiac output and pulmonary vascular resistance, and pulmonary vascular resistance is inversely proportional to the fourth power of the intraluminal radius of the pulmonary artery. Therefore, a very small decrease of the pulmonary vascular lumen diameter results in a significant increase in pulmonary vascular resistance and pulmonary arterial pressure. Pulmonary arterial hypertension is a fatal and progressive disease with poor prognosis. Regardless of the initial pathogenic triggers, sustained pulmonary vasoconstriction, concentric vascular remodeling, occlusive intimal lesions, in situ thrombosis, and vascular wall stiffening are the major and direct causes for elevated pulmonary vascular resistance in patients with pulmonary arterial hypertension and other forms of precapillary pulmonary hypertension. In this review, we aim to discuss the basic principles and physiological mechanisms involved in the regulation of lung vascular hemodynamics and pulmonary vascular function, the changes in the pulmonary vasculature that contribute to the increased vascular resistance and arterial pressure, and the pathogenic mechanisms involved in the development and progression of pulmonary hypertension. We focus on reviewing the pathogenic roles of membrane receptors, ion channels, and intracellular Ca signaling in pulmonary vascular smooth muscle cells in the development and progression of pulmonary hypertension.

Citing Articles

Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.

Zhang C, Zhong B, Jiang Q, Lu W, Wu H, Xing Y BMC Med. 2025; 23(1):148.

PMID: 40059138 PMC: 11892250. DOI: 10.1186/s12916-025-03982-7.


Emerging roles of mechanosensitive ion channels in ventilator induced lung injury: a systematic review.

Liu G, Dong B, Devanarayana S, Chen R, Liu Q Front Immunol. 2024; 15:1479230.

PMID: 39664395 PMC: 11631737. DOI: 10.3389/fimmu.2024.1479230.


Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease.

Signoretti C, Matsumura S, Fatehi S, DSilva M, Mathew R, Cendali F J Am Heart Assoc. 2024; 13(19):e035174.

PMID: 39291493 PMC: 11681449. DOI: 10.1161/JAHA.123.035174.


Animal models of pulmonary arterial hypertension associated with atrial septal defect.

Wang L, Tang T, Tian X, Peng C, Wu S Sci Rep. 2024; 14(1):18287.

PMID: 39112674 PMC: 11306221. DOI: 10.1038/s41598-024-69002-5.


Pathogenesis of cardiovascular diseases: effects of mitochondrial CF6 on endothelial cell function.

Zhao Y, Yang M, Liu Y, Wan Z, Chen M, He Q Mol Cell Biochem. 2024; 480(2):841-853.

PMID: 38985252 DOI: 10.1007/s11010-024-05065-2.


References
1.
Yu Y, Keller S, Remillard C, Safrina O, Nicholson A, Zhang S . A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation. 2009; 119(17):2313-22. PMC: 2749566. DOI: 10.1161/CIRCULATIONAHA.108.782458. View

2.
Qiao L, Nishimura T, Shi L, Sessions D, Thrasher A, Trudell J . Endothelial fate mapping in mice with pulmonary hypertension. Circulation. 2013; 129(6):692-703. DOI: 10.1161/CIRCULATIONAHA.113.003734. View

3.
Perez-Vizcaino F, Cogolludo A, Mondejar-Parreno G . Transcriptomic profile of cationic channels in human pulmonary arterial hypertension. Sci Rep. 2021; 11(1):15829. PMC: 8338963. DOI: 10.1038/s41598-021-95196-z. View

4.
Bhatnagar A, Wiesen J, Dweik R, Chaisson N . Evaluating suspected pulmonary hypertension: A structured approach. Cleve Clin J Med. 2018; 85(6):468-480. DOI: 10.3949/ccjm.85a.17065. View

5.
Sun H, Paudel O, Sham J . Increased intracellular Cl concentration in pulmonary arterial myocytes is associated with chronic hypoxic pulmonary hypertension. Am J Physiol Cell Physiol. 2021; 321(2):C297-C307. PMC: 8526344. DOI: 10.1152/ajpcell.00172.2021. View